New research reveals the significant impact severe allergies have on people’s daily lives and mental wellbeing, as well as uncovering an evident lack of awareness about the proper use of adrenaline pens.
Otsuka snaps up Jnana with its phenylketonuria drug for $800m
Otsuka will gain Jnana’s lead candidate JNT-517 for treating phenylketonuria (PKU), along with its drug discovery RAPID chemoproteomics platform. Image Credit: Ratana21 / Shutterstock. Otsuka
August 1, 2024